Inhibitors of ferroptosis Iron metabolism plays an important role in ferroptosis, and high iron levels have been shown to cause ferroptosis, suggesting iron chelation therapy may be an effective method to prevent ferroptosis

SELECT Trial: The Evidence for CV Coverage The SELECT trial (published in NEJM, November 2023) demonstrated that Wegovy reduces cardiovascular events: [27] 20% reduction in major adverse cardiovascular events (MACE) Includes heart attacks, strokes, and cardiovascular death 17,604 participants followed for ~3.3 years All participants had established cardiovascular disease plus obesity/overweight Typical Plan Coverage Criteria for CV Indication Medicare plans that cover Wegovy for cardiovascular risk reduction typically require: Clinical Criteria Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) BMI (body mass index) 27 kg/m No Type 2 diabetes (or T2D not adequately controlled) Concurrent lifestyle modifications (diet and exercise) Required Documentation Cardiology records documenting established CVD Current BMI (height and weight within last 30 days) Letter of Medical Necessity from cardiologist or primary care provider Documentation of lifestyle modification attempts ICD-10 Codes for CV vs

Consent for publication All authors have given consent for publication
Prior to commencing treatment, a comprehensive assessment is essential, including: Review of surgical history : time since surgery, type of procedure, post-operative complications, and current anatomical considerations
Getting Started Glutathione injections are more than a trendthey're a science-backed way to support the bodys natural detoxification systems, defend against oxidative stress, and potentially enhance skin radiance